Cargando…
Plasmodium falciparum proteome changes in response to doxycycline treatment
BACKGROUND: The emergence of Plasmodium falciparum resistance to most anti-malarial compounds has highlighted the urgency to develop new drugs and to clarify the mechanisms of anti-malarial drugs currently used. Among them, doxycycline is used alone for malaria chemoprophylaxis or in combination wit...
Autores principales: | Briolant, Sébastien, Almeras, Lionel, Belghazi, Maya, Boucomont-Chapeaublanc, Elodie, Wurtz, Nathalie, Fontaine, Albin, Granjeaud, Samuel, Fusaï, Thierry, Rogier, Christophe, Pradines, Bruno |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890676/ https://www.ncbi.nlm.nih.gov/pubmed/20500856 http://dx.doi.org/10.1186/1475-2875-9-141 |
Ejemplares similares
-
Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria
por: Fontaine, Albin, et al.
Publicado: (2010) -
Anopheles salivary gland proteomes from major malaria vectors
por: Fontaine, Albin, et al.
Publicado: (2012) -
Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline
por: Gaillard, Tiphaine, et al.
Publicado: (2015) -
PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria
por: Gaillard, Tiphaine, et al.
Publicado: (2013) -
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum
por: Parquet, Véronique, et al.
Publicado: (2010)